Covetrus Inc

Covetrus specializes in the production and distribution, inventory management, software and prescription management for veterinary care.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Semrush Holdings

BOSTON--(BUSINESS WIRE)--Semrush (NYSE: SEMR), a leading online visibility management SaaS platform, is pleased to announce that Veronique Montreuil joins the executive team as Chief Customer and Data Officer. With over 20 years of experience in customer success and customer experience, Veronique brings a wealth of expertise to enhance customer relationships and drive growth. In her most recent role as Head of Technology Sales and Customer Success at Covetrus (NASDAQ: CVET), Veronique led a tea.

Semrush Strengthens Customer Focus with Appointment of Veronique Montreuil as Chief Customer and Data Officer

PORTLAND, Maine--( BUSINESS WIRE )--Covetrus®, a global leader in animal-health technology and services, today announced the appointment of Ajoy Karna as executive vice president and chief financial officer. Karna succeeds Matthew Foulston, who announced previously his retirement from the company.

Covetrus Names Ajoy Karna as Chief Financial Officer

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus (“Covetrus” or the “Company”), a global leader in animal-health technology and services, today announced the successful completion of its previously announced acquisition by funds affiliated with Clayton, Dubilier & Rice (CD&R) and TPG Capital, the large-scale US and European private equity platform of global alternative asset management firm TPG (“TPG”).

Clayton, Dubilier & Rice and TPG Complete Acquisition of Covetrus

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Michelle Bonfilio as Chief People Officer, reporting to Ben Wolin, President and Chief Executive Officer at Covetrus. In this role, Bonfilio will oversee the human resources and communications organizations and help shape the culture of the company. “Michelle has a proven track record of empowering teams to achieve results, driving an inclusive

Covetrus Names Michelle Bonfilio as Chief People Officer

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Margie B. Pritchard as General Counsel and Corporate Secretary, reporting to Ben Wolin, President and Chief Executive Officer (CEO) at Covetrus. Prior to being named as General Counsel, Pritchard most recently served as Vice President, Deputy Counsel at Covetrus, where she was responsible for corporate and board governance, public reporting, ad

Covetrus Names Margie B. Pritchard General Counsel

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that Matthew Foulston, the Company's Executive Vice President and Chief Financial Officer, has informed the company that he will be retiring from the company effective December 31, 2022. Foulston's role at Covetrus caps off a strong career in which he has led technical, strategic and operational finance teams within a broad range of manufacturing, distribution an

Covetrus Announces Retirement of Matthew Foulston

Covetrus (CVET) delivered earnings and revenue surprises of 0% and 1.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Covetrus (CVET) Q2 Earnings Match Estimates

PORTLAND, Maine--(BUSINESS WIRE)---- $CVET #earnings--Covetrus Announces Financial Results for Second Quarter of 2022

Covetrus Announces Financial Results for Second Quarter of 2022

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus will release second quarter 2022 results before the markets open on Thursday, August 4, 2022.

Covetrus Announces Second Quarter 2022 Earnings Release Date

PORTLAND, Maine--(BUSINESS WIRE)--Animal health and technology services company, Covetrus, announces a new customer survey finding Covetrus Pulse saves time and is easy to implement.

Study Reveals New Covetrus Technology Saves Time, Provides Relief to Overworked, Understaffed Veterinary Practices

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, reminds investors it is investigating whether the directors of Covetrus, Inc. (“Covetrus”) (NASDAQ: CVET) breached their fiduciary duties to its shareholders in approving a buyout with funds affiliated with Clayton, Dubilier & Rice (“CD&R”) and TPG Capital (“TPG”) for inadequate consideration. If you are a Covetrus shareholder, you may contact att

COVETRUS, INC. INVESTIGATION CONTINUES: Scott+Scott Attorneys at Law LLP Investigates Clayton, Dubilier & Rice and TPG Capital Buyout of Covetrus, Inc – CVET

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Covetrus, Inc. (NasdaqGS: CVET) to funds affiliated with Clayton, Dubilier & Rice and TPG Capital. Under the terms of the proposed transaction, shareholders of Covetrus will receive only $21.00 in cash for each share of Covetrus that they own. KSF is seeking to determine whether this consideration and the

COVETRUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Covetrus, Inc. - CVET

NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether the directors of Covetrus, Inc. (“Covetrus”) (NASDAQ: CVET) breached their fiduciary duties to its shareholders in approving a buyout with funds affiliated with Clayton, Dubilier & Rice (“CD&R”) and TPG Capital (“TPG”) for inadequate consideration. If you are a Covetrus shareholder, you may contact attorney Joe Pettigrew f

Scott+Scott Attorneys at Law LLP Investigates Clayton, Dubilier & Rice and TPG Capital Buyout of Covetrus, Inc – CVET

NEW YORK , June 1, 2022 /PRNewswire/ --  Juan Monteverde , founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Covetrus, Inc . (CVET), relating to its proposed acquisition by funds affiliated with TPG Capital and Clayton, Dubilier & Rice.

Investor Alert - The M&A Class Action Firm Announces an Investigation of Covetrus, Inc. - CVET

NEW YORK , May 31, 2022 /PRNewswire/ -- Shareholder rights law firm Julie & Holleman has launched an investigation into the proposed acquisition of Covetrus, Inc. (NASDAQ: CVET) by funds affiliated with private equity firms Clayton, Dubilier & Rice (CD&R) and TPG Capital. To learn more about the investigation, click here.

CVET ALERT: Julie & Holleman Investigates Potential Legal Claims Related to Proposed Acquisition of Covetrus, Inc.

Wilmington, Delaware--(Newsfile Corp. - May 26, 2022) - Rigrodsky Law, P.A. is investigating Covetrus, Inc. ("CVET") (NASDAQ: CVET) regarding possible breaches of fiduciary duties and other violations of law related to CVET's agreement to be acquired by Clayton, Dubilier & Rice ("CD&R") and TPG Global, LLC ("TPG"). Under the terms of the agreement CVET's shareholders will receive $21.00 per share in cash.To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-covetrus-inc. To contact Seth...

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Covetrus, Inc. Buyout

Clayton, Dubilier & Rice (CD&R) and TPG announced a deal to buy Covetrus for about $4 billion. This is why.

Why Clayton Dubilier & Rice And TPG Are Buying Covetrus (CVET) In A $4 Billion Deal

NEW YORK, May 25, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Covetrus, Inc. ("Covetrus" or the "Company") (NASDAQ: CVET), in connection with the proposed acquisition of the Company by funds affiliated with Clayton, Dubilier & Rice and TPG Capital.  Under the terms of the merger agreement, the Company's shareholders will receive $21.00 in cash for each share of Covetrus common stock owned.

SHAREHOLDER ALERT: Weiss Law Investigates Covetrus, Inc.

MILWAUKEE , May 25, 2022 /PRNewswire/ -- -(PR NEWSWIRE)--Ademi LLP is investigating Covetrus (Nasdaq: CVET) for possible breaches of fiduciary duty and other violations of law in its transaction with Clayton, Dubilier & Rice and TPG Capital.  Click here to learn how to join the action: https://www.ademilaw.com/case/covetrus-inc or call Guri Ademi toll-free at 866-264-3995.

Shareholder Alert: Ademi LLP investigates whether Covetrus, Inc. has obtained a Fair Price in its transaction with Clayton, Dubilier & Rice and TPG Capital

Clayton, Dubilier & Rice (CD&R), a private investment firm, and TPG Capital will acquire animal-health technology and services company Covetrus Inc (NASDAQ: CVET) for $21.00 per share, representing an enterprise value of approximately $4 billion. CD&R and its affiliates.

CD&R, TPG Take Covetrus Private In $4B Deal

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Covetrus, Inc. (NASDAQ: CVET) to funds affiliated with Clayton, Dubilier & Rice (“CD&R”) and TPG Capital for $21.00 per share in cash is fair to Covetrus shareholders. Halper Sadeh encourages Covetrus shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpe

CVET Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Covetrus, Inc. Is Fair to Shareholders

Animal health company Covetrus Inc. CVET, -0.20% said Wednesday it agreed to be taken private by Clayton, Dubilier & Rice (CD&R) and TPG Capital TPG, -0.90% in a deal valued at $4 billion. The two private equity firms agreed to pay $21 a share, which is $1.34 or 6.8% over its closing price of $19.66 a share on Tuesday and a 39% premium over its 30-day volume weighted average price per share as of the unaffected stock price as of May 13.

Covetrus going private in $4 billion deal

Private-equity firms CD&R and TPG Capital will pay $21 a share to acquire the veterinary services company.

Covetrus to Be Taken Private for $4 Billion

PORTLAND, Maine--(BUSINESS WIRE)--Covetrus to Be Acquired by CD&R and TPG

Covetrus to Be Acquired by Clayton, Dubilier & Rice and TPG at an Enterprise Valuation of Approximately $4 Billion

CD&R and TPG offer to pay $21 a share in cash for Covetrus, which develops technologies and services for the animal health industry.

News for Covetrus Inc Stock (CVET)